0001179110-21-002796.txt : 20210303 0001179110-21-002796.hdr.sgml : 20210303 20210303193952 ACCESSION NUMBER: 0001179110-21-002796 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210301 FILED AS OF DATE: 20210303 DATE AS OF CHANGE: 20210303 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GOREVIC JASON N CENTRAL INDEX KEY: 0001208500 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37477 FILM NUMBER: 21711714 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Teladoc Health, Inc. CENTRAL INDEX KEY: 0001477449 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] IRS NUMBER: 043705970 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 MANHATTANVILLE ROAD STREET 2: SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 BUSINESS PHONE: 2036352002 MAIL ADDRESS: STREET 1: 2 MANHATTANVILLE ROAD STREET 2: SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 FORMER COMPANY: FORMER CONFORMED NAME: Teladoc, Inc. DATE OF NAME CHANGE: 20091123 4 1 edgar.xml FORM 4 - X0306 4 2021-03-01 0 0001477449 Teladoc Health, Inc. TDOC 0001208500 GOREVIC JASON N C/O TELADOC HEALTH, INC., 2 MANHATTANVILLE ROAD, SUITE 203 PURCHASE NY 10577 1 1 0 0 Chief Executive Officer Common Stock 2021-03-01 4 M 0 13281 A 540469 D Common Stock 2021-03-01 4 M 0 13944 A 554413 D Common Stock 2021-03-02 4 S 0 12674 224.282 D 541739 D Common Stock 2021-03-02 4 M 0 9104 A 550843 D Common Stock 2021-03-02 4 M 0 15476 A 566319 D Common Stock 2021-03-02 4 S 0 30000 223.5337 D 536319 D Restricted Stock Units 2021-03-01 4 M 0 13281 0 D Common Stock 13281 0 D Performance Stock Units 2021-03-01 4 M 0 13944 0 D Common Stock 13944 0 D Restricted Stock Units 2021-03-02 4 M 0 9104 0 D Common Stock 9104 18207 D Performance Stock Units 2021-03-02 4 A 0 46430 0 A Common Stock 46430 46430 D Performance Stock Units 2021-03-02 4 M 0 15476 0 D Common Stock 15476 30954 D Restricted Stock Units 2021-03-02 4 A 0 22944 0 A Common Stock 22944 22944 D Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit and performance stock unit awards. This transaction was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 4, 2020. Represents the weighted average price of transactions ranging from $216.40 to $231.14. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. On March 1, 2018, the reporting person was granted 39,842 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. On March 4, 2019, the reporting person earned 41,834 performance stock units, vesting in three substantially equal annual installments beginning on March 4, 2019 and March 1 each subsequent year. On March 2, 2020, the reporting person was granted 27,311 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. The performance stock units vest in three substantially equal annual installments beginning on March 2, 2021. On March 2, 2021, the reporting person earned 46,430 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2021. Each performance stock unit represents a contingent right to receive one share of TDOC common stock. Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. The restricted stock units vest in three substantially equal annual installments beginning on the first anniversary of the grant date. Performance award amount determined based on metrics in respect of the issuer's 2020 financial results. /s/ Adam C. Vandervoort, attorney-in-fact 2021-03-03